Developing new antimicrobial agents to fight drug-resistant bacteria
Control of Facial Amphiphilicity to Tune Macromolecular Interactions with Bacteria
['FUNDING_R01'] · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · NIH-10734759
This study is working on new types of antibiotics that can fight tough bacteria that don't respond to regular treatments, aiming to create safe and effective options for people dealing with stubborn infections.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA (nih funded) |
| Locations | 1 site (COLUMBIA, UNITED STATES) |
| Trial ID | NIH-10734759 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative antimicrobial compositions that can effectively combat multidrug-resistant bacteria. By utilizing nonspecific interactions, such as the attraction between charged groups and hydrophobic interactions, the study aims to design macromolecules that can evade bacterial resistance mechanisms. The approach involves engineering facial amphiphilicity in these macromolecules, which enhances their ability to target and kill Gram-negative pathogens while remaining safe for human cells. This could lead to the development of next-generation antibiotics that are more effective against stubborn bacterial infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by multidrug-resistant bacteria.
Not a fit: Patients with infections caused by bacteria that are not multidrug-resistant may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the creation of new antibiotics that are effective against drug-resistant bacterial infections.
How similar studies have performed: Other research has shown promise in developing antimicrobial agents using similar nonspecific interaction approaches, indicating potential for success in this novel strategy.
Where this research is happening
COLUMBIA, UNITED STATES
- UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA — COLUMBIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TANG, CHUANBING — UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
- Study coordinator: TANG, CHUANBING
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: bacteria infection, bacterial disease, Bacterial Infections